Antheia

Bioscience & Disease Healthcare Systems Materials, Natural Resources & Mining

Bioscience & Disease Healthcare Systems +1

Website LinkedIn Palo Alto, California, USA

About Antheia

Antheia Inc. is a next-generation pharmaceutical ingredient manufacturer that utilizes synthetic biology to produce medicines traditionally sourced from plants. The company aims to end drug shortages by creating essential medicines through advanced biosynthesis and genomics.

Business Information

Target Customers

pharmaceutical companies healthcare providers research institutions

Industry Categories

Bioscience & Disease Healthcare Systems Materials, Natural Resources & Mining

Business Model

Revenue Model B2B sales of pharmaceutical ingredients

Pricing Strategy Custom pricing based on contracts

Sales Channels direct sales, partnerships with pharmaceutical companies

Funding Timeline

Round	Date	Amount	Investors
Series C	Jun 03, 2025	$56.0M	Unknown

Founders

No founder information available.

Investors

No investor information available.

Recent Mentions

Raising.fi @raisingfi

Jun 03, 2025

New Raise 🏛️ Company: Antheia 🔗 Website: https://t.co/OZpZXcBG5R 📊 Amount: $56 Million 🔄 Round: Series C 🧮 Valuation: N/A ⚙️ Industry: Biotechnology, Healthcare

View on Twitter

Similar Startups

Antheia Bio

95% match

Antheia Bio is focused on delivering commercial-scale shipments of thebaine, a key starting material...

Therini Bio

88% match

Therini Bio is a biotechnology company focused on developing innovative therapeutics for neurodegene...

inductive_bio

87% match

A platform that accelerates the discovery of life-changing therapeutics using state-of-the-art AI mo...

biostateai

86% match

BiostateAI is an innovative company leveraging artificial intelligence and RNA sequencing technologi...